Genmab A/S ADR (GMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,715,000 | 1,380,000 | 2,158,688 | 1,400,849 | 1,425,059 |
| Marketable Securities | N/A | 1,574,000 | 1,926,514 | 1,760,230 | 1,651,617 |
| Receivables | 1,152,000 | 937,000 | 718,304 | 857,105 | 540,622 |
| Inventories | 18,000 | 9,000 | 8,276 | N/A | N/A |
| Other current assets | 0 | 0 | 0 | -1 | 0 |
| TOTAL | $2,885,000 | $3,900,000 | $4,811,783 | $4,018,183 | $3,617,298 |
| Non-Current Assets | |||||
| PPE Net | 153,000 | 137,000 | 138,666 | 113,138 | 98,801 |
| Investments And Advances | 37,000 | 32,000 | 19,457 | 18,833 | 59,026 |
| Intangibles | 9,478,000 | 2,083,000 | 14,665 | 20,674 | 40,411 |
| Other Non-Current Assets | 320,000 | 262,000 | 139,392 | 116,537 | 102,620 |
| TOTAL | $9,988,000 | $2,514,000 | $312,180 | $269,182 | $300,858 |
| Total Assets | $12,873,000 | $6,414,000 | $5,123,963 | $4,287,365 | $3,918,156 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 273,000 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,069,000 | 489,000 | 334,976 | 242,986 | 235,468 |
| Other current liabilities | 24,000 | 3,000 | N/A | N/A | N/A |
| TOTAL | $1,427,000 | $744,000 | $360,677 | $258,137 | $249,469 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,001,000 | N/A | N/A | N/A | N/A |
| Deferred Revenues | N/A | N/A | 4,792 | 4,673 | 4,137 |
| Other Non-Current Liabilities | 234,000 | 203,000 | 103,818 | 75,614 | 59,822 |
| TOTAL | $5,599,000 | $533,000 | $173,514 | $143,582 | $137,303 |
| Total Liabilities | $7,026,000 | $1,277,000 | $534,191 | $401,719 | $386,772 |
| Shareholders' Equity | |||||
| Common Shares | 10,000 | 10,000 | 9,583 | 9,346 | 10,501 |
| Retained earnings | 4,098,000 | 3,392,000 | 2,762,140 | 2,119,469 | 1,594,182 |
| Other shareholders' equity | -181,000 | -226,000 | 8,712 | 13,877 | 12,887 |
| TOTAL | $5,847,000 | $5,137,000 | $4,589,772 | $3,885,646 | $3,531,384 |
| Total Liabilities And Equity | $12,873,000 | $6,414,000 | $5,123,963 | $4,287,365 | $3,918,156 |